UK approves a daily pill for plaque psoriasis
The UK medicines regulator, the MHRA, has approved icotrokinra, a once-daily pill for moderate to severe plaque psoriasis. It can be used by adults and children aged 12 and up. Four large trials with 2500 people backed the approval. Common side effects include headache, nausea and cough. Psoriasis affects about 1 in 50 people, says the British Skin Foundation.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.